Julie Cooke insider trades: Neurocrine Biosciences (NBIX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Julie reports to the SEC
Open-market buys and sales
31 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 2, 2026 | NBIX | ↓ Sell | 36,937 | $156.22 | $5.8M | Direct | Jun 4, 2026 (2d) |
| Feb 13, 2025 | NBIX | ↓ Sell | 1,551 | $116.78 | $181K | Direct | Feb 14, 2025 (1d) |
| Feb 10, 2025 | NBIX | ↓ Sell | 700 | $118.28 | $83K | Direct | Feb 12, 2025 (2d) |
| Jan 31, 2025 | NBIX | ↓ Sell | 1,740 | $152.89 | $266K | Direct | Feb 4, 2025 (4d) |
| Aug 1, 2024 | NBIX | ↓ Sell | 12,632 | $153.26 | $1.9M | Direct | Aug 5, 2024 (4d) |
| Jul 16, 2024 | NBIX | ↓ Sell | 900 | $150.04 | $135K | Direct | Jul 18, 2024 (2d) |
| Jul 1, 2024 | NBIX | ↓ Sell | 10,000 | $140.19 | $1.4M | Direct | Jul 2, 2024 (1d) |
| Feb 13, 2024 | NBIX | ↓ Sell | 796 | $133.04 | $106K | Direct | Feb 15, 2024 (2d) |
| Feb 8, 2024 | NBIX | ↓ Sell | 2,544 | $138.61 | $353K | Direct | Feb 8, 2024 (0d) |
| Jan 31, 2024 | NBIX | ↓ Sell | 1,740 | $141.29 | $246K | Direct | Feb 2, 2024 (2d) |
| Dec 22, 2023 | NBIX | ↓ Sell | 24,000 | $128.66 | $3.1M | Direct | Dec 27, 2023 (5d) |
| Sep 1, 2023 | NBIX | ↓ Sell | 824 | $110.93 | $91K | Direct | Sep 6, 2023 (5d) |
| Aug 21, 2023 | NBIX | ↓ Sell | 2,132 | $107.41 | $229K | Direct | Aug 23, 2023 (2d) |
| May 1, 2023 | NBIX | ↓ Sell | 11,397 | $103.89 | $1.2M | Direct | May 3, 2023 (2d) |
| Apr 25, 2023 | NBIX | ↓ Sell | 100 | $103.82 | $10K | Direct | Apr 27, 2023 (2d) |
| Feb 8, 2023 | NBIX | ↓ Sell | 17,079 | $102.76 | $1.8M | Direct | Feb 8, 2023 (0d) |
| Jan 31, 2023 | NBIX | ↓ Sell | 916 | $108.48 | $99K | Direct | Feb 2, 2023 (2d) |
| Nov 8, 2022 | NBIX | ↓ Sell | 5,592 | $124.99 | $699K | Direct | Nov 10, 2022 (2d) |
| Nov 3, 2022 | NBIX | ↓ Sell | 8,408 | $125.00 | $1.1M | Direct | Nov 4, 2022 (1d) |
| Aug 5, 2022 | NBIX | ↓ Sell | 1,816 | $100.00 | $182K | Direct | Aug 9, 2022 (4d) |
| Jun 27, 2022 | NBIX | ↓ Sell | 754 | $100.00 | $75K | Direct | Jun 29, 2022 (2d) |
| Feb 8, 2022 | NBIX | ↓ Sell | 2,858 | $80.38 | $230K | Direct | Feb 9, 2022 (1d) |
| Oct 4, 2021 | NBIX | ↓ Sell | 987 | $101.73 | $100K | Direct | Oct 6, 2021 (2d) |
| Feb 8, 2021 | NBIX | ↓ Sell | 1,943 | $115.84 | $225K | Direct | Feb 9, 2021 (1d) |
| Nov 12, 2020 | NBIX | ↓ Sell | 2,257 | $90.73 | $205K | Direct | Nov 16, 2020 (4d) |
| Oct 2, 2020 | NBIX | ↓ Sell | 987 | $95.26 | $94K | Direct | Oct 6, 2020 (4d) |
| Aug 5, 2020 | NBIX | ↓ Sell | 2,257 | $118.91 | $268K | Direct | Aug 7, 2020 (2d) |
| Apr 24, 2020 | NBIX | ↓ Sell | 1,934 | $99.46 | $192K | Direct | Apr 28, 2020 (4d) |
| Feb 7, 2020 | NBIX | ↓ Sell | 913 | $103.26 | $94K | Direct | Feb 11, 2020 (4d) |
| Feb 5, 2020 | NBIX | ↓ Sell | 605 | $103.17 | $62K | Direct | Feb 7, 2020 (2d) |
| Oct 2, 2019 | NBIX | ↓ Sell | 987 | $88.56 | $87K | Direct | Oct 4, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NBIX insiders
Open-market trades in the last 12 months
About Julie Cooke's insider trades
Julie Cooke is Chief Human Resources Officer at Neurocrine Biosciences (NBIX). Since Oct 2, 2019, Julie has reported no open-market purchases and 31 sales worth $20.5M on SEC Form 4. In the last 12 months: 1 sale ($5.8M).
Their filings also include option exercises (13 filings), grants and awards (8 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.